Global law firm Ashurst represented Southeast Asian-focused private equity fund Altair Capital on its significant minority stake investment into Beyond Medical Group, a Singapore-based multi-disciplinary private specialist healthcare group.
Altair Capital is a private equity firm focused on buyout or significant minority investments in quality companies across Southeast Asia. It is owned and managed by Southeast Asian professionals with over 50 years’ combined experience of leading successful private equity investments in the ASEAN market. The Altair Capital leadership team comes with a strong track record in building values and helping portfolio companies strengthen their businesses through initial public offerings on regional exchanges such as Singapore, Hong Kong, United States, China, India, and Indonesia. Altair Capital is the ASEAN affiliate of Polaris Capital Group, a leading buyout group in Japan with over US$4 billion in assets under management.
Beyond Medical Group is an award-winning specialist health group covering a growing list of specialties such as cardiology, colorectal surgery, medical aesthetics, gastroenterology, neurosurgery, orthopedic, plastic surgery, thoracic surgery, and urology. To date, Beyond Medical Group holds a portfolio of 12 doctors and 16 centers in Singapore. It was named the “Best Progressive Medical Group of the Year in Asia-Pacific 2021” by GlobalHealth and the “Singapore SME500 Award 2022” by Singapore’s Association of Trade & Commerce.
Ashurst ADTLaw’s Head of M&A for Southeast Asia, Tao Koon Chiam commented: We are delighted to have assisted Altair Capital in its significant investment in Beyond Medical Group. This partnership combines Altair’s proven expertise in strategic management in Southeast Asia with Beyond Medical Group’s strong platform of specialist healthcare services, to meet the growing demand for quality healthcare in the region. We look forward to continuing to support Altair Capital in its investments into quality companies in Southeast Asia.
The transaction was led by Ashurst ADTLaw Director Yi Ming Choo, George Kho (Associate Director), Cheryl Chui (Associate) and Jia Fen Chan (Trainee Solicitor).
